Vapotherm Inc (NYSE:VAPO) reached a new 52-week high during trading on Tuesday . The company traded as high as $40.97 and last traded at $40.85, with a volume of 40628 shares trading hands. The stock had previously closed at $39.01.

A number of research analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Vapotherm from a “buy” rating to a “hold” rating in a research note on Thursday, June 18th. Canaccord Genuity upped their price objective on shares of Vapotherm from $30.00 to $34.00 and gave the company a “buy” rating in a research note on Friday, June 5th. BTIG Research reiterated a “buy” rating and set a $32.00 target price on shares of Vapotherm in a report on Tuesday, May 26th. ValuEngine cut Vapotherm from a “buy” rating to a “hold” rating in a report on Monday, March 30th. Finally, William Blair reiterated an “outperform” rating on shares of Vapotherm in a report on Thursday, March 5th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Vapotherm currently has a consensus rating of “Buy” and an average price target of $35.00.

The company has a debt-to-equity ratio of 1.01, a current ratio of 3.99 and a quick ratio of 3.56. The company has a 50-day simple moving average of $30.58 and a two-hundred day simple moving average of $17.69. The stock has a market capitalization of $856.88 million, a price-to-earnings ratio of -15.62 and a beta of -1.54.

Vapotherm (NYSE:VAPO) last released its quarterly earnings results on Tuesday, May 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.56) by ($0.10). Vapotherm had a negative return on equity of 109.58% and a negative net margin of 94.57%. The business had revenue of $19.12 million during the quarter, compared to the consensus estimate of $18.90 million. Research analysts anticipate that Vapotherm Inc will post -2.31 EPS for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the company. HighMark Wealth Management LLC grew its holdings in shares of Vapotherm by 50.0% during the 1st quarter. HighMark Wealth Management LLC now owns 1,500 shares of the company’s stock worth $28,000 after purchasing an additional 500 shares in the last quarter. Citigroup Inc. raised its position in Vapotherm by 241.6% in the 4th quarter. Citigroup Inc. now owns 3,047 shares of the company’s stock valued at $37,000 after purchasing an additional 2,155 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in Vapotherm in the 1st quarter valued at $43,000. BNP Paribas Arbitrage SA raised its position in Vapotherm by 118.7% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,645 shares of the company’s stock valued at $87,000 after purchasing an additional 2,521 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Vapotherm in the 1st quarter valued at $107,000. 57.59% of the stock is owned by institutional investors.

About Vapotherm (NYSE:VAPO)

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Read More: Futures Contract

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.